The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Central Nervous System (CNS) Therapeutic-Global Market Insights and Sales Trends 2024

Central Nervous System (CNS) Therapeutic-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1861320

No of Pages : 101

Ask Your Query

Synopsis

A central nervous system (CNS) disease can affect either the brain or the spinal cord which leads to neurological or psychiatric disorders.

The global Central Nervous System (CNS) Therapeutic market size is expected to reach US$ 93600 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of Central Nervous System (CNS) Therapeutic in various end use industries. The expanding demands from the Clinical Application and Others, are propelling Central Nervous System (CNS) Therapeutic market. Neurovascular, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Trauma segment is estimated at % CAGR for the next seven-year period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Central Nervous System (CNS) Therapeutic, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
 

This report provides in-depth analysis of the global Central Nervous System (CNS) Therapeutic market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Central Nervous System (CNS) Therapeutic market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Central Nervous System (CNS) Therapeutic sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Central Nervous System (CNS) Therapeutic covered in this report include Pfizer, Biogen, Johnson & Johnson, Eli Lilly, Otsuka America Pharmaceutical, Merck, Astrazeneca, Novartis and Teva Pharmaceutical Industries, etc.

The global Central Nervous System (CNS) Therapeutic market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • Pfizer
  • Biogen
  • Johnson & Johnson
  • Eli Lilly
  • Otsuka America Pharmaceutical
  • Merck
  • Astrazeneca
  • Novartis
  • Teva Pharmaceutical Industries
  • Takeda

Global Central Nervous System (CNS) Therapeutic market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Central Nervous System (CNS) Therapeutic market, Segment by Type:

  • Neurovascular
  • Trauma
  • Mental Health
  • Degenerative Disorder
  • Infections
  • Cancer

Global Central Nervous System (CNS) Therapeutic market, by Application

  • Clinical Application
  • Others

Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Central Nervous System (CNS) Therapeutic companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Index

1 Market Overview of Central Nervous System (CNS) Therapeutic
1.1 Central Nervous System (CNS) Therapeutic Market Overview
1.1.1 Central Nervous System (CNS) Therapeutic Product Scope
1.1.2 Central Nervous System (CNS) Therapeutic Market Status and Outlook
1.2 Global Central Nervous System (CNS) Therapeutic Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Central Nervous System (CNS) Therapeutic Market Size by Region (2018-2029)
1.4 Global Central Nervous System (CNS) Therapeutic Historic Market Size by Region (2018-2023)
1.5 Global Central Nervous System (CNS) Therapeutic Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Central Nervous System (CNS) Therapeutic Market Size (2018-2029)
1.6.1 North America Central Nervous System (CNS) Therapeutic Market Size (2018-2029)
1.6.2 Europe Central Nervous System (CNS) Therapeutic Market Size (2018-2029)
1.6.3 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size (2018-2029)
1.6.4 Latin America Central Nervous System (CNS) Therapeutic Market Size (2018-2029)
1.6.5 Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size (2018-2029)
2 Central Nervous System (CNS) Therapeutic Market by Type
2.1 Introduction
2.1.1 Neurovascular
2.1.2 Trauma
2.1.3 Mental Health
2.1.4 Degenerative Disorder
2.1.5 Infections
2.1.6 Cancer
2.2 Global Central Nervous System (CNS) Therapeutic Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Central Nervous System (CNS) Therapeutic Historic Market Size by Type (2018-2023)
2.2.2 Global Central Nervous System (CNS) Therapeutic Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Central Nervous System (CNS) Therapeutic Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Central Nervous System (CNS) Therapeutic Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Central Nervous System (CNS) Therapeutic Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Central Nervous System (CNS) Therapeutic Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Central Nervous System (CNS) Therapeutic Revenue Breakdown by Type (2018-2029)
3 Central Nervous System (CNS) Therapeutic Market Overview by Application
3.1 Introduction
3.1.1 Clinical Application
3.1.2 Others
3.2 Global Central Nervous System (CNS) Therapeutic Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Central Nervous System (CNS) Therapeutic Historic Market Size by Application (2018-2023)
3.2.2 Global Central Nervous System (CNS) Therapeutic Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Central Nervous System (CNS) Therapeutic Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Central Nervous System (CNS) Therapeutic Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Central Nervous System (CNS) Therapeutic Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Central Nervous System (CNS) Therapeutic Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Central Nervous System (CNS) Therapeutic Revenue Breakdown by Application (2018-2029)
4 Central Nervous System (CNS) Therapeutic Competition Analysis by Players
4.1 Global Central Nervous System (CNS) Therapeutic Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Central Nervous System (CNS) Therapeutic as of 2022)
4.3 Date of Key Players Enter into Central Nervous System (CNS) Therapeutic Market
4.4 Global Top Players Central Nervous System (CNS) Therapeutic Headquarters and Area Served
4.5 Key Players Central Nervous System (CNS) Therapeutic Product Solution and Service
4.6 Competitive Status
4.6.1 Central Nervous System (CNS) Therapeutic Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business
5.1.3 Pfizer Central Nervous System (CNS) Therapeutic Products, Services and Solutions
5.1.4 Pfizer Central Nervous System (CNS) Therapeutic Revenue (US$ Million) & (2018-2023)
5.1.5 Pfizer Recent Developments
5.2 Biogen
5.2.1 Biogen Profile
5.2.2 Biogen Main Business
5.2.3 Biogen Central Nervous System (CNS) Therapeutic Products, Services and Solutions
5.2.4 Biogen Central Nervous System (CNS) Therapeutic Revenue (US$ Million) & (2018-2023)
5.2.5 Biogen Recent Developments
5.3 Johnson & Johnson
5.3.1 Johnson & Johnson Profile
5.3.2 Johnson & Johnson Main Business
5.3.3 Johnson & Johnson Central Nervous System (CNS) Therapeutic Products, Services and Solutions
5.3.4 Johnson & Johnson Central Nervous System (CNS) Therapeutic Revenue (US$ Million) & (2018-2023)
5.3.5 Eli Lilly Recent Developments
5.4 Eli Lilly
5.4.1 Eli Lilly Profile
5.4.2 Eli Lilly Main Business
5.4.3 Eli Lilly Central Nervous System (CNS) Therapeutic Products, Services and Solutions
5.4.4 Eli Lilly Central Nervous System (CNS) Therapeutic Revenue (US$ Million) & (2018-2023)
5.4.5 Eli Lilly Recent Developments
5.5 Otsuka America Pharmaceutical
5.5.1 Otsuka America Pharmaceutical Profile
5.5.2 Otsuka America Pharmaceutical Main Business
5.5.3 Otsuka America Pharmaceutical Central Nervous System (CNS) Therapeutic Products, Services and Solutions
5.5.4 Otsuka America Pharmaceutical Central Nervous System (CNS) Therapeutic Revenue (US$ Million) & (2018-2023)
5.5.5 Otsuka America Pharmaceutical Recent Developments
5.6 Merck
5.6.1 Merck Profile
5.6.2 Merck Main Business
5.6.3 Merck Central Nervous System (CNS) Therapeutic Products, Services and Solutions
5.6.4 Merck Central Nervous System (CNS) Therapeutic Revenue (US$ Million) & (2018-2023)
5.6.5 Merck Recent Developments
5.7 Astrazeneca
5.7.1 Astrazeneca Profile
5.7.2 Astrazeneca Main Business
5.7.3 Astrazeneca Central Nervous System (CNS) Therapeutic Products, Services and Solutions
5.7.4 Astrazeneca Central Nervous System (CNS) Therapeutic Revenue (US$ Million) & (2018-2023)
5.7.5 Astrazeneca Recent Developments
5.8 Novartis
5.8.1 Novartis Profile
5.8.2 Novartis Main Business
5.8.3 Novartis Central Nervous System (CNS) Therapeutic Products, Services and Solutions
5.8.4 Novartis Central Nervous System (CNS) Therapeutic Revenue (US$ Million) & (2018-2023)
5.8.5 Novartis Recent Developments
5.9 Teva Pharmaceutical Industries
5.9.1 Teva Pharmaceutical Industries Profile
5.9.2 Teva Pharmaceutical Industries Main Business
5.9.3 Teva Pharmaceutical Industries Central Nervous System (CNS) Therapeutic Products, Services and Solutions
5.9.4 Teva Pharmaceutical Industries Central Nervous System (CNS) Therapeutic Revenue (US$ Million) & (2018-2023)
5.9.5 Teva Pharmaceutical Industries Recent Developments
5.10 Takeda
5.10.1 Takeda Profile
5.10.2 Takeda Main Business
5.10.3 Takeda Central Nervous System (CNS) Therapeutic Products, Services and Solutions
5.10.4 Takeda Central Nervous System (CNS) Therapeutic Revenue (US$ Million) & (2018-2023)
5.10.5 Takeda Recent Developments
6 North America
6.1 North America Central Nervous System (CNS) Therapeutic Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Central Nervous System (CNS) Therapeutic Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Central Nervous System (CNS) Therapeutic Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Central Nervous System (CNS) Therapeutic Market Dynamics
11.1 Central Nervous System (CNS) Therapeutic Industry Trends
11.2 Central Nervous System (CNS) Therapeutic Market Drivers
11.3 Central Nervous System (CNS) Therapeutic Market Challenges
11.4 Central Nervous System (CNS) Therapeutic Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock